Clinical trial to treat rectal cancer spares major surgery

A multicentre clinical trial coordinated by the University of Birmingham has demonstrated that a chemoradiotherapy treatment with selective rectum-preserving surgery can allow 80% of early-stage rectal cancer patients to avoid major surgery. This approach offers a potential new standard of care that reduces severe side effects and improves quality of life.

This Wire brief sits within Fusion42's coverage of Health.